Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement

Dirk De Ruysscher*, Gilles Defraene, Bram L. T. Ramaekers, Philippe Lambin, Erik Briers, Hilary Stobart, Tim Ward, Soren M. Bentzen, Tjeerd Van Staa, David Azria, Barry Rosenstein, Sarah Kerns, Catharine West

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)440-446
JournalRadiotherapy and Oncology
Volume121
Issue number3
DOIs
Publication statusPublished - Dec 2016

Keywords

  • Trial design
  • Patient selection
  • Radiogenomics
  • Biomarkers

Cite this